Zhang M, Liu F, Gao W, Liu Z
J Nat Med. 2025; .
PMID: 39966243
DOI: 10.1007/s11418-024-01869-0.
Deng Z, Zhang L, Sun C, Liu Y, Li B
Heliyon. 2024; 10(19):e38488.
PMID: 39391470
PMC: 11466623.
DOI: 10.1016/j.heliyon.2024.e38488.
Skubic C, Trcek H, Nassib P, Kreft T, Walakira A, Pohar K
iScience. 2024; 27(9):110651.
PMID: 39262789
PMC: 11387598.
DOI: 10.1016/j.isci.2024.110651.
Zhang L, Wang I, Meng S, Xu J
Int J Mol Sci. 2024; 25(14).
PMID: 39062918
PMC: 11276818.
DOI: 10.3390/ijms25147677.
Ordonez-Rubiano E, Rincon-Arias N, Espinosa S, Shelton W, Salazar A, Combita A
Curr Res Pharmacol Drug Discov. 2024; 7:100193.
PMID: 39055532
PMC: 11268206.
DOI: 10.1016/j.crphar.2024.100193.
MicroRNA-34 and gastrointestinal cancers: a player with big functions.
Gao W, Zhou J, Morshedi M
Cancer Cell Int. 2024; 24(1):163.
PMID: 38725047
PMC: 11084024.
DOI: 10.1186/s12935-024-03338-w.
MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer.
Oda T, Tsutsumi K, Obata T, Ueta E, Kikuchi T, Ako S
Mol Ther Oncol. 2024; 32(1):200765.
PMID: 38596294
PMC: 10963938.
DOI: 10.1016/j.omton.2024.200765.
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.
Fu J, Imani S, Wu M, Wu R
Cancers (Basel). 2023; 15(19).
PMID: 37835417
PMC: 10571940.
DOI: 10.3390/cancers15194723.
Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.
Moravcik R, Olejarova S, Zlacka J, Herichova I
PLoS One. 2023; 18(10):e0292880.
PMID: 37831728
PMC: 10575541.
DOI: 10.1371/journal.pone.0292880.
miR-34a-FOXP1 Loop in Ovarian Cancer.
Dirimtekin E, Mortoglou M, Alavanda C, Benomar Yemlahi A, Arslan Ates E, Guney I
ACS Omega. 2023; 8(30):27743-27750.
PMID: 37546627
PMC: 10399168.
DOI: 10.1021/acsomega.3c03867.
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.
Hu Q, Huang T
Int J Mol Sci. 2023; 24(10).
PMID: 37240281
PMC: 10219488.
DOI: 10.3390/ijms24108939.
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer.
Hwang T, Cuiu Y, Chen Y, Chen P, Tsai T, Chou K
Int J Oncol. 2023; 62(5).
PMID: 37083075
PMC: 10147313.
DOI: 10.3892/ijo.2023.5514.
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.
Treeck O, Haerteis S, Ortmann O
Cancers (Basel). 2023; 15(6).
PMID: 36980520
PMC: 10046587.
DOI: 10.3390/cancers15061632.
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies.
Zhou X, Wang X, Li N, Guo Y, Yang X, Lei Y
Front Pharmacol. 2023; 14:1114295.
PMID: 36874032
PMC: 9978534.
DOI: 10.3389/fphar.2023.1114295.
The Dynamics of miR-449a/c Expression during Uterine Cycles Are Associated with Endometrial Development.
Naydenov M, Nikolova M, Apostolov A, Glogovitis I, Salumets A, Baev V
Biology (Basel). 2023; 12(1).
PMID: 36671747
PMC: 9855972.
DOI: 10.3390/biology12010055.
Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.
Dorai S, Alex Anand D
Cells. 2022; 11(23).
PMID: 36497125
PMC: 9740537.
DOI: 10.3390/cells11233867.
The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.
Ahmed Adam M, Kamal L, Kanakal M, Babu D, Dahham S, Tabana Y
Int J Mol Sci. 2022; 23(19).
PMID: 36233156
PMC: 9570345.
DOI: 10.3390/ijms231911856.
USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11.
Huang G, Liao J, Wang M, Huang Y, Tang M, Hao Y
Mediterr J Hematol Infect Dis. 2022; 14(1):e2022048.
PMID: 35865393
PMC: 9266782.
DOI: 10.4084/MJHID.2022.048.
Testicular miRNAs and tsRNAs provide insight into gene regulation during overwintering and reproduction of Onychostoma macrolepis.
Peng G, Zhu C, Sun Q, Li J, Chen Y, Guo Y
Fish Physiol Biochem. 2022; 48(3):481-499.
PMID: 35595880
DOI: 10.1007/s10695-022-01078-0.
Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions.
Yi W, Tu M, Yu A, Lin J, Yu A
Bioengineered. 2022; 13(5):12489-12503.
PMID: 35579419
PMC: 9276019.
DOI: 10.1080/21655979.2022.2076399.